MDCX (Medicus Pharma Ltd) Bathi resik

MDCX (medicuspharma.com) - tandha merek perusahaan

The profit volume of Medicus Pharma Ltd. (MDCX) reflects the impact of cheap liquidity, with the current figure standing at -0.04. Medicus Pharma Ltd. is implementing recycled plastics and eliminating toxins from ointment compositions in accordance with ESG standards. The issuer is developing microneedles for the clinical therapy of basal cell carcinoma. Meanwhile, the potential of the new patches is only beginning to materialize, while early tests are already priced in.

MDCX (Medicus Pharma Ltd.) riwayat Bathi resik perusahaan saka 15.11.2024 nganti 30.10.2026

Rincian metrik keuangan lan pasar Medicus Pharma (MDCX)

- rega lan prakiraan konsensus rega:
Kutipan saham Medicus Pharma Corp|MDCX - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Medicus Pharma Corp|MDCX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Akuntansi Saham Medicus Pharma|MDCX - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku medicuspharma.com|MDCX - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Medicus Pharma Ltd.|MDCX - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Medicus Pharma Ltd|MDCX - Utang perusahaan|Rasio utang marang nilai buku Medicus Pharma Corp|MDCX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Medicus Pharma|Likuiditas darurat medicuspharma.com
- indikator pendapatan resik lan kelipatan nilai:
MDCX - Bathi resik
Analisis dhasar perusahaan:Medicus Pharma Corp
Produk asil prodhuksi Medicus Pharma Limited

Medicus Pharma Ltd. (MDCX) focus on the organic promotion of its sole dermatological asset makes operational efficiency a critical factor for business survival. By analyzing the company's net profit dynamics, investors track the final financial result for each session, which allows them to identify the real pace of innovation capitalization prior to official SEC reports and confirm the fundamental stability of market quotes.

Pesaing utama

Penghasilan resik Krystal Biotech Corp.|APGE (Apogee Therapeutics) - Bathi resik|Bathi resik arcutis.com|Penghasilan resik VCEL (Vericel)|ORKA (Oruka Therapeutics, Inc.) - Bathi pungkasan|Bathi resik perusahaan Sanara MedTech SMTI|Asil keuangan resik DBV Tech (DBVT)|SLSN - Bathi resik perusahaan|DERM - Bathi resik|FBRX: Bathi resik|EMPG - Asil keuangan resik|Bathi resik perusahaan Sol-Gel|Bathi perusahaan AXIL (Revive Pro Care)|Bathi resik perusahaan Verrica Pharmaceuticals (VRCA)|Penghasilan resik hoththerapeutics.com HOTH|Bathi resik BFRI (Biofrontera)|VYNE Therapeutics, Inc. (VYNE) - Penghasilan resik perusahaan|Sonoma Pharma - Bathi resik|QNRX (Quoin Pharmaceuticals) - Bathi perusahaan|AZTR: Bathi resik|DRMA - Asil keuangan resik|ELAB (Elevai Labs) - Bathi resik|Penghasilan resik Revance Therapeutics Inc. (RVNC)